SCHEMBL7455599

SCHEMBL7455599

O=C1NC(Cc2ccc(OCc3nc(-c4ccccc4)cs3)cc2)C(=O)S1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARD Q03181 3/20 0.44
PPARA Q07869 2/20 0.44
ALOX5 P09917 3/20 0.44
MAPT P10636 4/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
TDP1 Q9NUW8 1/20 0.41
POLB P06746 1/20 0.39
FFAR1 O14842 1/20 0.39
LOXL2 Q9Y4K0 1/20 0.38
KMT2A Q03164 3/20 0.37
MEN1 O00255 2/20 0.37
NPSR1 Q6W5P4 1/20 0.37
NPC1 O15118 1/20 0.37
ALDH1A1 P00352 1/20 0.37
CD74 P04233 1/20 0.37
MIF P14174 1/20 0.37
RAB9A P51151 1/20 0.37
HPGD P15428 2/20 0.37
TAAR1 Q96RJ0 1/20 0.37
HTR3A P46098 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1848107 0.80 PPARG (0.47) MAPTL3MBTL1KMT2AMEN1NPSR1
SCHEMBL7455591 0.80 FFAR1 (0.63) PPARAFFAR1
SCHEMBL1746646 0.78 FFAR1 (0.63) PPARAFFAR1KMT2AMEN1HPGD
SCHEMBL7454602 0.77 FFAR1 (0.56) PPARAFFAR1KMT2AMEN1HPGD
SCHEMBL9326656 0.76 HRH3 (0.48) PPARAFFAR1KMT2AMEN1HPGD
SCHEMBL8030739 0.75 PPARG (0.59) PPARAMAPTFFAR1
SCHEMBL10365334 0.73 FFAR1 (0.38) PPARAALOX5MAPTFFAR1KMT2A
SCHEMBL1747427 0.72 FFAR1 (0.52) PPARAFFAR1KMT2AMEN1HPGD
SCHEMBL8653167 0.72 PPARD (0.45) PPARDPPARAALOX5MAPTL3MBTL1
SCHEMBL4940660 0.71 GAA (0.44) POLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0804193-A4 THIAZOLIDINE DERIVATIVES FOR THE TREATMENT OF PSORIASIS KURTZ THEODORE W (US) 2002-03-27 EP disclosed
US-6110951-A LOWERING INSULIN DRUG THERAPY IN NON-OBESE, NON-DIABETIC INDIVIDUALS BETHESDA PHARMACEUTICALS, INC. 2000-08-29 US disclosed
EP-0804193-A1 THIAZOLIDINE DERIVATIVES FOR THE TREATMENT OF PSORIASIS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1997-11-05 EP disclosed
US-5594015-A Thiazolidine derivatives for the treatment of psoriasis REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1997-01-14 US disclosed
WO-1995035108-A1 THIAZOLIDINE DERIVATIVES FOR THE TREATMENT OF PSORIASIS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1995-12-28 WO disclosed
US-5053420-A Antidiabetic agents KURTZ, THEODORE W. 1991-10-01 US disclosed
EP-0208420-B1 THIAZOLIDINE DERIVATIVES, THEIR PRODUCTION AND USE Takeda Chemical Industries, Ltd. (JP) 1991-09-18 EP disclosed
WO-1991005538-A2 THIAZOLIDINE DERIVATIVES FOR THE TREATMENT OF HYPERTENSION PERSHADSINGH HARRIHAR A (US) 1991-05-02 WO disclosed
US-4775687-A ANTIDIABETIC AGENTS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1988-10-04 US disclosed
EP-0208420-A1 Thiazolidine derivatives, their production and use Takeda Chemical Industries, Ltd. (JP) 1987-01-14 EP disclosed